198 related articles for article (PubMed ID: 31907582)
1. Cyclosporin A activates human hepatocellular carcinoma (HepG2 cells) proliferation: implication of EGFR-mediated ERK1/2 signaling pathway.
Abo-El Fetoh ME; Helal GK; Saleh IG; Ewees M; ElShafey M; Elnagar MR; Akool ES
Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):897-908. PubMed ID: 31907582
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A and tacrolimus induce renal Erk1/2 pathway via ROS-induced and metalloproteinase-dependent EGF-receptor signaling.
Akool el-S; Gauer S; Osman B; Doller A; Schulz S; Geiger H; Pfeilschifter J; Eberhardt W
Biochem Pharmacol; 2012 Jan; 83(2):286-95. PubMed ID: 22100870
[TBL] [Abstract][Full Text] [Related]
3. PEG-SOD attenuates the mitogenic ERK1/2 signaling cascade induced by cyclosporin A in the liver and kidney of albino mice.
Yousef A; Saleh IG; Abd-Allah ARA; Elnagar MR; Akool ES
Chem Biol Interact; 2020 Oct; 330():109245. PubMed ID: 32866465
[TBL] [Abstract][Full Text] [Related]
4. Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.
Li X; Lv Y; Yuan A; Yi S; Ma Y; Li Z
Oncol Rep; 2010 Aug; 24(2):441-8. PubMed ID: 20596631
[TBL] [Abstract][Full Text] [Related]
5. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
6. CXCL12/CXCR4 axis triggers the activation of EGF receptor and ERK signaling pathway in CsA-induced proliferation of human trophoblast cells.
Zhao HB; Tang CL; Hou YL; Xue LR; Li MQ; Du MR; Li DJ
PLoS One; 2012; 7(7):e38375. PubMed ID: 22848341
[TBL] [Abstract][Full Text] [Related]
7. Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway.
Yue P; Gao ZH; Xue X; Cui SX; Zhao CR; Yuan Y; Yin Z; Inagaki Y; Kokudo N; Tang W; Qu XJ
Eur J Cancer; 2011 May; 47(7):1115-24. PubMed ID: 21349701
[TBL] [Abstract][Full Text] [Related]
8. Chlorpyrifos promotes colorectal adenocarcinoma H508 cell growth through the activation of EGFR/ERK1/2 signaling pathway but not cholinergic pathway.
Suriyo T; Tachachartvanich P; Visitnonthachai D; Watcharasit P; Satayavivad J
Toxicology; 2015 Dec; 338():117-29. PubMed ID: 26514924
[TBL] [Abstract][Full Text] [Related]
9. Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells.
Yan F; Wang M; Li J; Cheng H; Su J; Wang X; Wu H; Xia L; Li X; Chang HC; Li Q
Environ Toxicol Pharmacol; 2012 Mar; 33(2):181-90. PubMed ID: 22222560
[TBL] [Abstract][Full Text] [Related]
10. Albumin activates ERK via EGF receptor in human renal epithelial cells.
Reich H; Tritchler D; Herzenberg AM; Kassiri Z; Zhou X; Gao W; Scholey JW
J Am Soc Nephrol; 2005 May; 16(5):1266-78. PubMed ID: 15829704
[TBL] [Abstract][Full Text] [Related]
11. Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling.
Chen G; Qiu H; Ke SD; Hu SM; Yu SY; Zou SQ
World J Gastroenterol; 2013 Apr; 19(16):2481-91. PubMed ID: 23674849
[TBL] [Abstract][Full Text] [Related]
12. Sirt6 suppresses hepatocellular carcinoma cell growth via inhibiting the extracellular signal‑regulated kinase signaling pathway.
Zhang ZG; Qin CY
Mol Med Rep; 2014 Mar; 9(3):882-8. PubMed ID: 24366394
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
14. Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinib.
Matsuo M; Sakurai H; Ueno Y; Ohtani O; Saiki I
Cancer Sci; 2006 Feb; 97(2):155-62. PubMed ID: 16441427
[TBL] [Abstract][Full Text] [Related]
15. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
[TBL] [Abstract][Full Text] [Related]
16. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
[TBL] [Abstract][Full Text] [Related]
17. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.
Maretzky T; Evers A; Zhou W; Swendeman SL; Wong PM; Rafii S; Reiss K; Blobel CP
Nat Commun; 2011; 2():229. PubMed ID: 21407195
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus and cyclosporine A alter barrier function in renal proximal tubular cells through stimulation of ERK1/2 signaling and claudin-1 expression.
Martin-Martin N; Ryan G; McMorrow T; Ryan MP
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F672-82. PubMed ID: 19955189
[TBL] [Abstract][Full Text] [Related]
19. P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells.
Ratchford AM; Baker OJ; Camden JM; Rikka S; Petris MJ; Seye CI; Erb L; Weisman GA
J Biol Chem; 2010 Mar; 285(10):7545-55. PubMed ID: 20064929
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A upregulates ETB receptor in vascular smooth muscle via activation of mitogen-activating protein kinases and NF-κB pathways.
Zheng JP; Cheng Z; Jiang J; Ke Y; Liu Z
Toxicol Lett; 2015 May; 235(1):1-7. PubMed ID: 25772258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
